Search Results (226)
Click the Why column to see why an item matched the search.
| Match | Type | Why |
|---|
| Identification of human long noncoding RNAs associated with nonalcoholic fatty liver disease and metabolic homeostasis. | Academic Article |
Why?
|
| Sokol, Ronald | Person |
Why?
|
| Activation of AMPD2 drives metabolic dysregulation and liver disease in mice with hereditary fructose intolerance. | Academic Article |
Why?
|
| Validation of a screening panel for pediatric metabolic dysfunction-associated steatotic liver disease using metabolomics. | Academic Article |
Why?
|
| PKM2-dependent metabolic skewing of hepatic Th17 cells regulates pathogenesis of non-alcoholic fatty liver disease. | Academic Article |
Why?
|
| Soft drinks consumption is associated with nonalcoholic fatty liver disease independent of metabolic syndrome in Chinese population. | Academic Article |
Why?
|
| Metabolic disturbances in non-alcoholic fatty liver disease. | Academic Article |
Why?
|
| Bile acids for babies? Diagnosis and treatment of a new category of metabolic liver disease. | Academic Article |
Why?
|
| Endogenous Fructose Production and Metabolism Drive Metabolic Dysregulation and Liver Disease in Mice with Hereditary Fructose Intolerance. | Academic Article |
Why?
|
| The metabolic syndrome and nonalcoholic fatty liver disease in children. | Academic Article |
Why?
|
| Non-alcoholic fatty liver disease and subclinical atherosclerosis: A comparison of metabolically- versus genetically-driven excess fat hepatic storage. | Academic Article |
Why?
|
| Nonalcoholic fatty liver disease as a contributor to hypercoagulation and thrombophilia in the metabolic syndrome. | Academic Article |
Why?
|
| Presence of the metabolic syndrome in obese adolescents predicts impaired glucose tolerance and nonalcoholic fatty liver disease. | Academic Article |
Why?
|
| Low awareness of nonalcoholic fatty liver disease among patients at high metabolic risk. | Academic Article |
Why?
|
| Disparities in metabolic dysfunction-associated steatotic liver disease and cardiometabolic conditions in low and lower middle-income countries: a systematic analysis from the global burden of disease study 2019. | Academic Article |
Why?
|